DS
LLY icon

DRW Securities’s Eli Lilly LLY Stock Holding History

DRW Securities’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-800
Closed -$736K – 1255
2026
Q1 		$736K Sell
800
-3,700
-82% -$3.75M 0.01% 436
2025
Q4 		$4.84M Sell
4,500
-2,700
-38% -$2.58M 0.13% 122
2025
Q3 		$5.49M Buy
7,200
+2,900
+67% +$2.16M 0.1% 116
2025
Q2 		$3.35M Sell
4,300
-21,300
-83% -$16.6M 0.08% 143
2025
Q1 		$21.1M Buy
+25,600
New +$21.3M 0.59% 33
2024
Q3 		– Sell
-500
Closed -$456K – 652
2024
Q2 		$456K Sell
500
-200
-29% -$160K 0.02% 337
2024
Q1 		$545K Buy
+700
New +$498K 0.01% 220

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DRW Securities's LLY Position: Q2 2026 in Review

DRW Securities sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 459 shares — an estimated $469K sold.

DRW Securities first reported a position in LLY in Q4 2017 and held it in 20 quarters. The position peaked at $9.1M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • DRW Securities reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 459 Eli Lilly shares in Q2 2026, an estimated $469K.
  • DRW Securities first reported a position in Eli Lilly in Q4 2017 and held it in 20 quarters.
  • DRW Securities's Eli Lilly position peaked at $9.1M in Q1 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.